Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo vs. KBP: How a $1.3B deal turned into an international legal fight
AI and Machine Learning
Biotech
AstraZeneca pens fresh IBD collab with Immunai worth $85M
AstraZeneca has returned to its longtime AI partner Immunai with a new deal worth up to $85 million to advance a target for a new IBD therapy.
James Waldron
Oct 16, 2025 9:00am
Flagship's Lila adds $115M to series A, bringing total to $350M
Oct 14, 2025 11:33am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
Shuttle Pharma launches into AI drug discovery via $10M buy
Oct 10, 2025 7:00am
Sanofi inks pact with Canadian tech company to bring AI to R&D
Oct 8, 2025 12:13pm
Spanish oncology group infuses AI into breast cancer trials
Oct 7, 2025 6:05am
